• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Ethical Issues in International Biomedical Research: A Casebook

    Ethical Issues in International Biomedical Research by Lavery, James V.; Grady, Christine; Wahl, Elizabeth R.;

    A Casebook

      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice GBP 66.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        31 531 Ft (30 030 Ft + 5% VAT)
      • Discount 10% (cc. 3 153 Ft off)
      • Discounted price 28 378 Ft (27 027 Ft + 5% VAT)

    31 531 Ft

    db

    Availability

    printed on demand

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher OUP USA
    • Date of Publication 22 March 2007

    • ISBN 9780195179224
    • Binding Hardback
    • No. of pages400 pages
    • Size 163x236x25 mm
    • Weight 686 g
    • Language English
    • 0

    Categories

    Short description:

    The ethics of biomedical research in developing countries is hotly debated. Utilising 21 cases of actual research trials, this book explores a wide range of ethical challenges in conducting research in developing countries. Commentaries are provided by leading scholars on international research ethics as well as by many new voices, including authors from developing countries.

    More

    Long description:

    Ethical Issues in International Biomedical Research is the definitive book on the ethics of research involving human subjects in developing countries. Using 21 actual case studies, it covers the most controversial topics, including the ethics of placebo research in Africa, what benefits should be provided to the community after completion of a research trial, how to address conflicts between IRBs in developed and developing countries, and undue inducement of poor people in developing countries. Each case is accompanied by two expert commentaries, written by many of the worlds leading experts in bioethics as well as new voices with research experience in developing countries. No other volume has this scope.

    This is a well-written book and a must-read for anyone trying to understand the concerns associated with international biomedical research. The cases address research in many parts of the world on different disorders and conditions. The commentaries give readers a better appreciation of the breadth and depth of the relevant ethical issues.

    More

    Table of Contents:

    FOREWORD
    INTRODUCTION
    SECTION I: COLLABORATIVE PARTNERSHIP
    Case 1. Community involvement in biodiversity prospecting in Mexico
    Case 2. Selling genes: consulting a genetic population database in Tonga
    Case 3: Substantiality of a fluoride varnish feasability study in Nicaragua
    SECTION II: SCIENTIFIC VALIDITY
    Case 4: Malarone testing in pregnant women in Thailand
    Case 5: Neglected diseases: Incentives to Conduct Research in Developing Countries: the case of Pharamomycin for visceral leishmaniasis in India
    SECTION III: SCIENTIFIC VALIDITY
    Case 7. The limitations of knowledge: equipsoise and a randomized treatment strategy for malaria in Ethiopia
    Case 8. Controversy surrounding the scientific value of the Vaxgen/Aventis (RV-144) Phase III
    SECTION IV: FAIR SUBJECT AND COMMUNITY SELECTION
    Case 9. Pharmaceutical research in developing countries: testing a new sufracant in Bolivia
    Case 10: Trading Genes for Toothbrushes: Research with the Aka Pygmy people in the Central African Republic
    Case 11: Test Phase I malaria vaccine: where should the research be conducted?
    SECTION V: FAVOURABLE RISK/BENEFIT ASSESSMENT
    Case 12: Ethical complcations during an investigation of malaria infection in native Amazonian populations in western Brazil
    Case 13: Access to treatment for trial participants who become infected with HIV during the course of Phase I trials of a preventive HIV vaccine in South Africa
    SECTION VI: INDEPENDENT REVIEW
    Case 14: How independent is independent review? Partner notification in a study of sexually-transmitted diseases in Mpumalanga, South Africa
    Case 15: Which regulations protect subjects best: preventing HIV status disclosure in a community-based circumcision study in rural Uganda
    SECTION VII: INFORMED CONSENT
    Case 16: The challenge of informed consent in a genetic epidemiology study of noma in rural Nigeria
    Case 17: Compensation to families who consent to research autopsy for their children in a study of malaria mortality in Malawi: respectful or coercive?
    SECTION VIII: RESPECT FOR ENROLLED SUBJECTS AND THEIR COMMUNITIES
    Case 18: A randomized trial of low-phytate corn for maternal-infant micronutrient deficiency in Guatemala
    Case 19: Obligations to participants harmed in the course of the N-9 multi-centre vaginal microbicide trial in South Africa
    Case 20: Ethical challenges and controversy in a retrospective study of HIV-1 transmission in Uganda
    Case 21: Protecting subjects in a study of domestic violence in South Africa: what services are researchers obligated to provide?
    APPENDIX I: ECONOMIC, SOCIAL, HEALTH AND DEVELOPMENT INDICATORS FOR THE CASE COUNTRIES

    More
    0